| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total revenue | 2,305 | 2,404 | ||
| Cost Of Goods And Services Sold | 922 | 870 | ||
| Total cost of revenue | 922 | 870 | ||
| Gross profit | 1,383 | 1,534 | ||
| Research and development | 739 | 704 | ||
| Sales and marketing | 683 | 679 | ||
| General and administrative | 1,540 | 1,961 | ||
| Total operating expenses | 2,962 | 3,344 | ||
| Loss from operations | -1,579 | -1,810 | ||
| Change in fair value of warrant liabilities | 4,309 | 624 | ||
| Loss upon issuance of convertible notes carried at fair value | - | 0 | ||
| Interest expense, net | -13 | -13 | ||
| Change in fair value of convertible notes | - | 0 | ||
| Other income (expense), net | 1,009 | -219 | ||
| Total other (expense) income, net | -3,313 | -856 | ||
| Net loss | -4,892 | -2,666 | ||
| Earnings per share, basic | -0.13 | -0.07 | ||
| Earnings per share, diluted | -0.13 | -0.07 | ||
| Weighted average number of shares outstanding, basic | 36,388,370 | 35,564,032 | ||
| Weighted average number of shares outstanding, diluted | 36,388,370 | 35,564,032 | ||
Aspira Women's Health Inc. (AWHL)
Aspira Women's Health Inc. (AWHL)